ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy?
作者信息
Pennington Thomas E, Thompson John F, Varey Alex H R
机构信息
Melanoma Institute Australia, Wollstonecraft, NSW, Australia.
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
出版信息
Ann Surg Oncol. 2025 Jun;32(6):4225-4226. doi: 10.1245/s10434-024-16821-5. Epub 2024 Dec 27.
PMID:39730968
Abstract
摘要
Zotero 插件